BCYC · Bicycle Therapeutics PLC
$4.01
+0.15 (+3.89%)
At close · Jul 30
Market Cap
$280.67M
Shares
69.99M
Bicycle Therapeutics PLC Earnings Call Transcripts
Every quarterly earnings call for Bicycle Therapeutics PLC (BCYC) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼82.3%
$1.13M
−$11.32M
'20 Q1
20-05-07
▲525.7%
$3.84M
−$10.14M
'20 Q3
20-11-05
▲76.1%
$5.35M
−$49.90M
'23 Q3
23-11-02
▲298.9%
$19.53M
−$26.56M
'24 Q1
24-05-02
▼30.4%
$3.71M
−$51.85M
'24 Q4
25-02-25
▼48.9%
$9.98M
−$60.75M
'25 Q1
25-05-01
▼68.8%
$2.92M
−$78.95M
'25 Q2
25-08-08
LATEST
▲338.5%
$11.73M
−$59.10M
'25 Q3
25-10-30
Earnings call
FY25 · Q3
2025-10-30
Bicycle Therapeutics PLC Q3 FY2025 Earnings Call
Revenue
$11.73M
▲ 338.5% YoY Diluted EPS
$-0.85
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-08
Bicycle Therapeutics PLC Q2 FY2025 Earnings Call
Revenue
$2.92M
▼ 68.8% YoY Diluted EPS
$-1.14
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-01
Bicycle Therapeutics PLC Q1 FY2025 Earnings Call
Revenue
$9.98M
▼ 48.9% YoY Diluted EPS
$-0.88
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
Bicycle Therapeutics PLC Q4 FY2024 Earnings Call
Revenue
$3.71M*
▼ 30.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q1
2024-05-02
Bicycle Therapeutics PLC Q1 FY2024 Earnings Call
Revenue
$19.53M
▲ 298.9% YoY Diluted EPS
$-0.62
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q3
2023-11-02
Bicycle Therapeutics PLC Q3 FY2023 Earnings Call
Revenue
$5.35M
▲ 76.1% YoY Diluted EPS
$-1.26
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q3
2020-11-05
Bicycle Therapeutics PLC Q3 FY2020 Earnings Call
Revenue
$3.84M
▲ 525.7% YoY Diluted EPS
$-0.52
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Bicycle Therapeutics PLC Q1 FY2020 Earnings Call
Revenue
$1.13M
▼ 82.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–8 of 8 earnings calls
Key facts
CIK
1761612
CUSIP
088786108
13F (30d)
14 filings
14 filers
Visit website
Investor relations